
1.49 BATS BZX Real-Time Price As of 12:43pm ET | ![]() Today’s Change | 0.41 Today|||52-Week Range 7.79 | -40.60% Year-to-Date |
Biotech Stock Roundup: EPZM Soars on IPSEY Offer, KZR Up on Study Data & More Jun 29 / Zacks.com - Paid Partner Content | Why Epizyme Stock Is Soaring Today Jun 27 / MotleyFool.com - Paid Partner Content |
Why Adaptimmune Therapeutics Stock Is Popping Today Jun 27 / MotleyFool.com - Paid Partner Content | Epizyme (EPZM) Stock Surges on Acquisition Offer From Ipsen Jun 27 / Zacks.com - Paid Partner Content |
Previous close | 1.50 |
Today’s open | 1.49 |
Day’s range | 1.49 - 1.50 |
Volume | 68,154 |
Average volume (3 months) | 3,233,017 |
Market cap | $250.8M |
Earnings growth (last year) | -6.61% |
Earnings growth (this year) | +43.57% |
Earnings growth (next 5 years) | +38.00% |
Revenue growth (last year) | +137.45% |
P/E ratio | NM |
Price/Sales | 6.86 |
Price/Book | -- |
Today’s change | Today’s % change | |
---|---|---|
OTLKOutlook Therapeutics... | +0.01 | +0.90% |
XOMAXOMA Corp | +1.42 | +6.32% |
ALDXAldeyra Therapeutics... | +0.20 | +4.71% |
RYTMRhythm Pharmaceutica... | +0.07 | +1.48% |
Next reporting date | August 10, 2022 |
EPS forecast (this quarter) | -$0.36 |
Annual revenue (last year) | $37.4M |
Annual profit (last year) | -$251.1M |
Net profit margin | -670.96% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |